Skin·3 min read

This experimental “super vaccine” stopped cancer cold in the lab

By InsideWellness Editorial · October 13, 2025

Originally published by ScienceDaily Skin Care.

UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, pancreatic, and triple-negative breast cancers in mice—with up to 88% remaining tumor-free. The vaccine triggers a multi-pathway immune response, producing powerful T-cell activation and long-term immune

Read the full article on ScienceDaily Skin Care →

This summary appears courtesy of ScienceDaily Skin Care. Read the full article on ScienceDaily Skin Care

About the author

InsideWellness Editorial

Our editorial team curates and writes on wellness research, beauty science, and evidence-backed lifestyle insights. See our editorial standards for how we source and review content.

More to read

Stay informed

Join our weekly digest of evidence-backed wellness research.